UroGen Pharma Ltd. earnings per share and revenue

URGN earnings per share for the last quarter are -0.97 USD whereas the estimation was -0.87 USD which accounts for -11.93% surprise. Företagets omsättning för samma period uppgår till 18.78 M USD trots den uppskattade siffran 21.39 M USD. Estimated earnings per share for the next quarter are -0.85 USD, and revenue is expected to reach 23.76 M USD. Also watch annual changes over time to get a bigger picture of URGN earnings per share and revenue dynamics.